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best discriminatory properties. The increased diagnostic accuracy may be due to the 
wider	 symptom	 range	 of	 the	WURS	 and/or	 the	 retrospective	 childhood	 frame	 of	
symptoms.
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Signif icant Outcomes
•	 The	 Norwegian	 Wender	 Utah	 Rating	 Scale	 (WURS)	 and	 Adult	
ADHD	 Self-Report	 Scale	 (ASRS)	 were	 validated,	 both	 demon-
strating excellent screening properties.
• Retrospective childhood symptoms of aggressiveness and social 
problems are highly predictive of an adult diagnosis of atten-
tion-deficit hyperactivity disorder.
• Our results support that emotional regulation problems consti-
tute	a	large	part	of	ADHD	symptomatology	in	childhood.
Limitat ions
• The use of retrospective self-report measures might be affected 
by memory biases and lack of recall.
•	 The	use	of	self-report	measures	for	present	ADHD	symptoms	may	
be biased by the current health and life situation of the informant.
•	 This	 study	 was	 based	 on	 a	 sample	 diagnosed	 with	 ADHD	 as	




neurodevelopmental	 disorder	with	 childhood	 onset,	 characterized	
by	inattention,	hyperactivity,	and	impulsivity	(American	Psychiatric	
Association,	 2013).	ADHD	has	 a	 prevalence	of	 about	 5%	 in	 child-
hood	(Polanczyk,	de	Lima,	Horta,	Biederman,	&	Rohde,	2007),	with	
about	half	persisting	into	adulthood	(Faraone	et	al.,	2015).	As	con-












and	 easy	way	 of	 obtaining	 standardized	 information	 to	 select	 pa-
tients for further examination.
It	is	important	to	establish	a	history	of	childhood	ADHD	symp-
toms,	as	the	pharmacological	treatment	of	ADHD	involves	regulated	
substances and as several other disorders that appear in adulthood 
may	display	ADHD	 symptoms	 (e.g.,	 affective	 disorders,	 substance	
use	disorders,	 and	 sleep	disorders;	Haavik	et	 al.,	 2010).	To	add	 to	
the	 complexity,	 these	 disorders	may	 often	 also	 be	 comorbid	with	
ADHD.	The	Wender	Utah	Rating	Scale	 (WURS)	was	developed	 to	























and	Roy-Byrne	 (2000)	named	 the	 factors	Dysthymia,	Oppositional/
Defiant Behavior,	and	School Problems	while	Caci,	Bouchez,	and	Baylé	
(2010)	 named	 the	 factors	 Impulsivity/Temper,	 Inattentiveness,	 and	
Mood/Self-esteem.	 Stanton	 and	 Watson	 (2016)	 recently	 reported	
factors Aggression,	Internalizing Distress,	and	Academic Difficulties of 
the	WURS	in	a	community	sample.
Current symptoms of inattention and/or hyperactivity and im-
pulsivity	 are	 also	 essential	 for	 the	 diagnosis	 of	 ADHD	 to	 be	 made	
in	adulthood.	The	Adult	ADHD	Self-Report	Scale	 (ASRS)	 is	 the	offi-
cial	 screening	 instrument	 of	 the	World	Health	Organization	 (WHO;	
Kessler	et	al.,	2005),	and	 includes	the	18	 items	ADHD	symptoms	of	
the	DSM.	It	is	one	of	the	most	commonly	used	screening	instruments	










tioning	 (i.e.,	 not	part	of	 the	ADHD	defining	 symptoms).	They	 found	
this to have good psychometric properties as a general population 
screener.	 However,	 another	 small	 nonclinical	 study	 comparing	 the	
short screener to the full 18 items version found the lengthy version to 
have	better	psychometric	properties	(Zohar	&	Konfortes,	2010).	The	
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controls.	The	ASRS	and	the	25-item	WURS	have	been	translated	into	
several	languages,	including	Norwegian.	Validation	studies	of	multiple	
versions have shown similar psychometric properties to those re-
ported	for	the	original	English	versions	(Caci	et	al.,	2010;	Kessler	et	al.,	




we are not aware of official validation studies.
The	aims	of	the	present	study	were	threefold:	first,	to	establish	
the	construct	and	content	validity	of	the	Norwegian	translations	of	
the	WURS	and	 the	ASRS	using	principal	 component	analysis;	 sec-
ond,	to	examine	the	psychometric	properties	of	the	WURS	and	the	
ASRS	in	a	large	clinically	diagnosed	adult	ADHD	patient	sample	and	











approved	 by	 one	 out	 of	 three	 expert	 committees	 (situated	 in	Oslo,	
Trondheim	and	Bergen).	When	this	protocol	was	terminated	in	2005,	
the	same	diagnostic	protocol	was	continued,	but	without	the	manda-
tory extra approval. Experienced clinical psychologists and psychia-
trists made the diagnostic assessment in routine practice in outpatient 
clinics,	according	to	 the	10th	revision	of	 the	 International	Statistical	
Classification	 of	 Diseases	 and	 Related	 Health	 Problems	 (ICD-10;	
WHO,	 1992),	 with	 allowances	 for	 the	 subtypes	 described	 in	 the	
DSM-IV-TR	 (American	Psychiatric	Association,	 2000).	 Patients	were	
included in the registry regardless of the final decision to administer 
stimulants as part of their treatment. Comorbidities were assessed and 
allowed as comorbidities are found to be highly prevalent among pa-
tients	with	ADHD,	with	mood	and	anxiety	disorders,	 substance	use	
disorders,	and	personality	disorders	being	the	most	frequent,	increas-
ing	 the	 ecological	 validity	 of	 the	 final	 sample	 (Faraone	 et	 al.,	 2015;	
Haavik	et	al.,	2010;	Halmoy,	Fasmer,	Gillberg,	&	Haavik,	2009;	Halmoy	











toms and related problems experienced in childhood. Participants 
responded	to	 these	 items	on	a	Likert-type	5-point	scale	according	
to	 the	 following	 response	 categories:	 “not	 at	 all/very	 slightly”	 (0),	
“mildly”	(1),	“moderately”	(2),	quite	a	bit”	(3),	or	“very	much”	(4),	giv-
ing	a	possible	range	of	0–100	points.
2.2.2 | The Adult ADHD Self-Report Scale
The	 Adult	 ADHD	 Self-Report	 Scale	 (ASRS)	 is	 a	 brief	 screening	




activity,	 and	 impulsivity	 defining	 ADHD	 according	 to	 the	 DSM-
IV-TR	and	DSM-5	(American	Psychiatric	Association,	2000,	2013).	
The	 severity	 of	 the	 symptoms	 are	 reported	 on	 a	 5-point	 Likert-
type	scale	 (0–4	=	never,	rarely,	sometimes,	often,	to	very	often),	
with	a	total	range	of	0–72.	The	total	ASRS	score	has	shown	good	
reliability and validity in both clinical and population samples 
(Adler	et	al.,	2006;	Glind	et	al.,	2013).
2.3 | Statistics and analytic plan
A	Principal	 Component	Analysis	 (PCA)	with	Varimax	 rotation	was	
run	to	establish	how	the	items	of	the	WURS	and	the	ASRS	contrib-
uted	to	given	components,	selecting	components	with	Eigenvalues	






mulas	 from	 Fischer,	 Bachmann	 (Fischer,	 Bachmann,	 &	 Jaeschke,	






Cronbach's alpha was calculated to measure internal consistency 
in	the	resulting	factors	of	the	WURS	and	ASRS.	SPSS	version	24.0	
was	used	for	the	statistical	analyses	(IBM	26).
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3  | RESULTS
The present study included n	=	646	clinically	assessed	adult	ADHD	
patients and n	=	908	controls,	 resulting	 in	a	 total	sample	of	1,554	
participants.	The	mean	ages	were	34.0	(SD 10.3)	years	in	the	ADHD	
group	and	29.4	 (SD 7.8)	years	 in	the	control	group	 (p < .01). There 
were	48.5%	females	in	the	ADHD	group	and	59.9%	females	in	the	
control	 group	 (p	 <	 .01).	 The	 total	 WURS	 and	 ASRS	 scores	 were	
strongly	correlated	(full	sample	r	=	.78,	p	<	.001;	ADHD	group	r	=	.36,	
p < .001; controls r	 =	 .70,	p	 <	 .001).	 Figure	 1	 shows	 the	 distribu-
tions	of	WURS	and	ASRS	scores	in	the	ADHD	and	control	samples,	
including	the	correlation	between	the	two.	For	a	subset	of	patients,	
we also obtained clinician ratings on whether the patients were 






child	 scored	significantly	higher	on	both	 the	ASRS	and	 the	WURS	
compared to those patients who reported no childhood treatment. 
Mean	scores	on	the	ASRS	and	WURS	for	the	ADHD	group	and	the	
control	 group,	 as	 well	 as	 for	 the	 different	 subgroups	 within	 the	
ADHD	group,	are	shown	in	Table	1.
3.1 | Factor analyses
The Principal Component analysis generated a three-factor solution 
for	the	WURS	items	in	the	full	sample	(Table	2)	explaining	69.2%	of	
the	variance.	This	solution	offered	high	item	loadings	on	each	scale,	
with a few exceptions. The highest loading items on the first fac-
tor	were	“Temper	outbursts,	Tantrums”	and	“Angry”,	including	items	
of defiant behavior. The highest loading items on the second fac-
tor	were	 “Overall	a	poor	student,	Slow	 learner”	and	 “Trouble	with	
mathematics	or	numbers,”	 also	 including	 items	of	 inattention.	The	
items	with	 the	 highest	 loading	 on	 the	 third	 factor	were	 “Anxious,	
Worrying”	and	“Sad	or	blue,	Depressed,	Unhappy.”	We	thus	named	
the three factors Aggressiveness and social problems,	 Learning and 
attention problems and Dysthymia,	 respectively.	 Only	 the	 item	












TA B L E  1  Group	differences	on	the	ASRS	and	the	WURS
 
Controls 
(n = 908) ADHD (n = 646)
Currently on 
medication (n = 420)
Currently off 
medication (n = 125)
No childhood 
treatment (n = 530)
Received childhood 
treatment (n = 89)
ASRS 23.0	(9.8) 45.0	(12.6)** 43.5	(13.3) 48.1	(10.4)** 31.4	(14.4) 41.5	(12.7)*
WURS 17.3	(13.9) 58.2	(17.9)** 58.0	(18.3) 58.6	(17.0) 32.5	(25.2) 55.1	(18.9)**
Note: Mean	scores	with	standard	deviations	(SD)	in	parentheses.	The	comparisons	were	pair	wise,	with	the	four	comparison	groups	on	the	right	being	
subgroups	within	the	adult	ADHD	group.
*p < .01. 
**p < .001. 
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“Unpopular	with	other	children	[…]”	had	ambiguous	loading	with	fac-
tor loadings below 0.50 on all factors. Internal consistency meas-
ured	by	Cronbach's	alpha	was	0.967	for	the	full	WURS,	and	0.954	for	
Aggressiveness and social Problems,	0.919	for	Learning and attention 
problems	and	0.897	for	Dysthymia,	respectively.
A	 two-factor	 solution	 was	 generated	 for	 the	 ASRS	 in	 the	 full	
sample	(Table	3),	explaining	62.2%	of	the	variance.	The	first	factor	
included	items	reflecting	symptoms	of	inattention,	the	second	factor	
symptoms of hyperactivity and impulsivity. The items reflecting im-
pulsive behavior obtained the highest loadings on the second factor.
Internal	 consistency	measured	 by	 Cronbach's	 alpha	was	 0.952	
for	the	full	ASRS	score,	0.924	for	the	Inattentive	factor	and	0.918	for	
the	Hyperactivity/Impulsivity	factor.
3.2 | The discriminative ability of the 
WURS and the ASRS






shown). The optimal cutoff balancing the trade-off between sensi-
tivity and specificity for the respective scales may vary depend-
ing on the aims in the specific clinical or research setting. Table 4 
provides	cutoff	values	for	98%,	95%,	90%	and	80%	sensitivity	and	
TA B L E  2  Rotated	factor	component	matrix	for	the	WURS
As a child I was (or had)
Component
1 2 3
Aggressiveness	and	Social	Problems	(30.7% of the variance) 
WURS	6:	Temper	outbursts,	tantrums 0.817 0.204 0.235
WURS	14:	Angry 0.811 0.172 0.318
WURS	5:	Hot-	or	short-tempered,	low	boiling	point 0.785 0.242 0.261
WURS	10:	Disobedient	with	parents,	rebellious,	sassy 0.746 0.214 0.137
WURS	19:	Losing	control	of	myself 0.740 0.342 0.328
WURS	12:	Irritable 0.738 0.247 0.401
WURS	8:	Stubborn,	strong-willed 0.673 0.242 0.475
WURS	13:	Moody,	ups	and	downs 0.672 0.403 0.336
WURS	20:	Tendency	to	be	or	act	irrational 0.662 0.154 0.090
WURS	15:	Trouble	seeing	things	from	someone	else's	point	of	view 0.652 0.390 0.115
WURS	22:	Trouble	with	authorities,	trouble	with	school,	visits	to	principal's	office 0.635 0.374 0.230




Learning	and	Attention	Problems	(19.5% of the variance)
WURS	23:	Overall	a	poor	student,	slow	learner 0.229 0.783 0.195
WURS	24:	Trouble	with	mathematics	or	numbers 0.147 0.757 0.209
WURS	25:	Not	achieving	up	to	potential 0.312 0.730 0.370
WURS	1:	Concentration	problems,	easily	distracted 0.459 0.694 0.310
WURS	7:	Trouble	with	stick-to-it-tiveness,	not	following	through,	failing	to	finish	things	started 0.369 0.595 0.427
WURS	4:	Inattentive,	daydreaming 0.519 0.587 0.330
WURS	17:	Tendency	to	be	immature 0.432 0.542 0.308
Dysthymia	(19.0% of the variance)
WURS	2:	Anxious,	worrying 0.200 0.240 0.814
WURS	9:	Sad	or	blue,	depressed,	unhappy 0.313 0.151 0.799
WURS	11:	Low	opinion	of	myself 0.166 0.265 0.754
WURS	18:	Guilty	feelings,	regretful 0.230 0.280 0.728
WURS	3:	Nervous,	fidgety 0.334 0.377 0.684
Note: PCA	with	Varimax	rotation	on	the	WURS	in	the	full	sample.	Items	sorted	by	factor	loadings.	Total	variance	explained	by	the	three-factor	
solution:	69.2%.
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TA B L E  3  Rotated	factor	component	matrix	for	the	ASRS
Circle the number that best describes how you have felt and conducted yourself over the past 6 months
Component
1 2
































F I G U R E  2   Receiving operator curve 







item sum. Yellow line represents the 
ASRS	Short	screener	used	dichotomously.	
A	steeper	curve	indicates	better	
















ASRS Short screener sum
ASRS
WURS
ASRS and WURS combined
Source of the Curve
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specificity,	respectively,	for	both	the	WURS	and	the	ASRS,	including	
LHs	and	DORs	for	each	cutoff.	Using	sum	scores	from	all	the	factors	




Both	 the	WURS	 and	 the	 ASRS	 had	 excellent	 screening	 and	 psy-
chometric	 properties,	 with	 somewhat	 stronger	 properties	 for	 the	
WURS.	The	recommended	short	screener	ASRS	performed	as	well	
as	the	full	ASRS.	A	Principal	Component	analysis	confirmed	a	three-
factor	 structure	 of	 the	WURS	 described	 in	 previous	 studies	 (Caci	
et	al.,	2010;	Kouros,	Horberg,	Ekselius,	&	Ramklint,	2018;	McCann	
et	al.,	2000;	Stanton	&	Watson,	2016),	albeit	with	some	differences	





The delineation of disorder versus normality is a universal prob-
lem when a diagnosis is based on symptoms that are dimensional and 
normally	distributed,	and	it	is	of	particular	concern	in	a	disorder	for	
which controlled stimulant substances with potential for abuse are 
first-line	treatments	(McGough	&	Barkley,	2004).	Thus,	establishing	
validity and accuracy of the two most commonly used screening in-
struments	is	vital.	Contrary	to	the	critique	raised	against	the	WURS	
for	 lacking	content	validity	 (i.e.,	diverging	from	the	DSM	symptom	
criteria;	 Stanton	&	Watson,	 2016),	we	 found	 a	 very	 high	 criterion	
validity	of	WURS	(i.e.,	being	highly	predictive	of	an	ADHD	diagno-
sis). The items driving this discriminatory ability were part of the 
Learning and attention problems	factor	of	the	WURS.	The	items	rep-
resent	behaviors	well	recognized	as	core	ADHD	symptoms	(WURS	
1: Concentration problems, easily distracted	and	WURS	7:	Trouble with 








be more distinct but nevertheless part of the combined presenta-
tion	of	adult	ADHD	 (Haavik	et	 al.,	2010;	Shaw,	Stringaris,	Nigg,	&	
Leibenluft,	2014).	In	a	recent	study,	both	executive	function	deficits	




noteworthy as our patients were diagnosed as adults based on a 
comprehensive	 clinical	 evaluation	 following	 the	 ICD/DSM	criteria.	
Thus,	even	strictly	defined	adult	ADHD	patients	are	more	easily	dis-
tinguished from controls with a broader childhood symptom array 
than	the	current	DSM	core	symptoms.	This	fits	well	with	the	well-es-
tablished	 finding	 that	 ADHD	 is	 characterized	 by	 childhood	 onset	












frame and spanning over a longer period of time may furthermore 
elicit responses that separate better between adult patients with 
TA B L E  4  Predictive	validity	of	the	WURS	and	the	ASRS
Sensitivity
WURS 
score (Specificity) LH+ LH− DOR
ASRS 
score (Specificity) LH+ LH− DOR
0.98 21 (0.71) 3.38 0.03 135.5 16 (0.22) 1.26 0.09 14.6
0.95 29 (0.83) 5.59 0.06 95.6 21 (0.45) 1.73 0.11 18.0
0.90 35 (0.88) 7.50 0.11 64.7 27 (0.71) 3.10 0.14 23.6
0.80 42 (0.93) 11.43 0.22 56.1 35 (0.88) 6.67 0.23 30.8
Specificity  (Sensitivity)     (Sensitivity)    
0.98 56 (0.55) 27.5 0.46 53.4 49 (0.45) 22.5 0.56 34.0
0.95 46 (0.75) 15 0.26 54.5 42 (0.64) 12.8 0.38 32.7
0.90 36 (0.89) 8.9 0.12 63.5 36 (0.79) 7.9 0.23 32.0
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ADHD	 and	 controls.	 Another	 possible	 explanation	 for	 the	 better	
screening	properties	of	the	WURS	could	be	that	some	of	the	patients	










The present findings should be viewed in light of some limitations. 
There are problems related to the use of self-report measures be-









(2016)	 found	 that	 current	mood	 symptoms	 do	 not	 affect	 the	 ac-
curacy	of	retrospective	self-ratings	of	childhood	ADHD	symptoms.	
A	 recent	 study	 has	 found	 that	 the	 WURS	 even	 has	 acceptable	
retest	 reliability	 over	 the	 time	 span	of	 several	 years	 (Lundervold,	
Vartiainen,	Jensen,	&	Haavik,	2019).	The	ASRS	on	the	other	hand	
may be more affected by short-term confounders such as affec-
tive	fluctuations	(Lundervold	et	al.,	2011),	time	of	day	(Franke	et	al.,	
2012)	 and	 sleep	 problems	 (Benjamins	 et	 al.,	 2016;	 Brevik	 et	 al.,	
2017).	Comorbid	psychiatric	disorders	could	have	influenced	find-
ings,	but	to	maintain	external	validity	we	chose	not	to	control	for	
these,	 as	 ADHD	 is	 more	 often	 comorbid	 than	 not	 (Singh,	 2008;	
Sobanski,	2006).
This	 study	was	 based	 on	 an	 adult	ADHD	 sample	 ascertained	 in	
adulthood,	meaning	that	it	is	uncertain	whether	the	patients	included	






We used a clinically validated patient sample and a represen-
tative	 population	 control	 sample,	 which	 strengthens	 the	 clinical	








The	Norwegian	 translation	 of	 both	 the	 ASRS	 and	 the	WURS	 had	
excellent psychometric properties and can be used independently 
for	screening	and	diagnostic	assessment	for	ADHD.	We	found	that	
the	WURS	had	even	better	screening	properties	than	the	ASRS,	in	
spite of our sample being clinically assessed and diagnosed in adult-
hood.	The	wider	WURS	dimensions	of	aggression,	learning	problems	
and	emotional	lability	were	highly	relevant	to	identify	adult	ADHD	
in	 our	 sample,	 supporting	 a	 broader	 conceptualization	 of	 ADHD.	
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